Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KETOPROFEN LYSINE vs KETOROLAC TROMETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

KETOPROFEN LYSINE vs KETOROLAC TROMETHAMINE: Safety Overview

Metric KETOPROFEN LYSINE KETOROLAC TROMETHAMINE
Total FAERS Reports 380 6,160
Deaths Reported 1 235
Death Rate 0.3% 3.8%
Hospitalizations 177 1,332
Average Patient Age 40.8 yrs 49.7 yrs
% Female Patients 55.3% 62.0%
FDA Approval Date N/A Apr 26, 1999
Manufacturer N/A ASCLEMED USA INC.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued